Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.63
-0.06 (-3.55%)
At close: Jun 13, 2025, 3:59 PM
1.63
0.00%
After-hours: Jun 13, 2025, 05:50 PM EDT
Marker Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|
| Grant Revenue | 6.59M | 3.51M | 466.79K | 213.19K | 205.99K |
| Grant Revenue Growth | +87.59% | +652.71% | +118.95% | +3.50% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Oct 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.37M | 1.03M | 854.68K | 1.14M | 1.22M | 1.03M | 1.41M | 2.52M | 2.52M | 1.89M | 3.23M | 3.52M | 3.73M | 2.99M | 3.24M | 3.56M | 3.14M | 2.52M | 2.57M | 2.55M | 2.83M | 1.91M | 2.54M | 2.72M | 2.81M | 17.18M | 2.55M | 3.05M | 1.6M | 1.25M | 2.55M | 1.19M | 1.43M | 1.14M | 1.61M | 1.18M | 767.99K | 2.12M | 968.76K | 936.89K | 418.79K |
| Selling, General, and Administrative Revenue Growth | +33.30% | +20.16% | -25.16% | -6.24% | +18.37% | -27.18% | -43.91% | +0.12% | +32.84% | -41.43% | -7.99% | -5.84% | +24.89% | -7.72% | -8.99% | +13.42% | +24.28% | -1.87% | +1.02% | -9.90% | +47.70% | -24.53% | -6.80% | -3.03% | -83.67% | +573.38% | -16.44% | +91.05% | +28.35% | -51.16% | +114.02% | -16.60% | +25.81% | -29.59% | +36.96% | +53.26% | -63.83% | +119.15% | +3.40% | +123.71% | n/a |
| Research and Development Revenue | 3.13M | 5.09M | 3.47M | 2.33M | 2.58M | 2.62M | 2.04M | 2.38M | 7.27M | 5.27M | 3.59M | 6.55M | 7.03M | 8.02M | 6.78M | 7.35M | 5.64M | 5.98M | 4.8M | 4.28M | 3.82M | 3.66M | 3.12M | 3.15M | 2.83M | 118.69M | 1.88M | 1.83M | 1.6M | 1.44M | 1.62M | 1.2M | 989.09K | 456.79K | 1.11M | 1.25M | 985.75K | 131.42K | 769.22K | 201.16K | 609.38K |
| Research and Development Revenue Growth | -38.36% | +46.53% | +48.65% | -9.32% | -1.60% | +27.97% | -14.00% | -67.29% | +38.05% | +46.63% | -45.20% | -6.70% | -12.36% | +18.18% | -7.70% | +30.25% | -5.68% | +24.54% | +12.32% | +12.05% | +4.26% | +17.38% | -1.05% | +11.26% | -97.61% | +6223.60% | +2.74% | +14.19% | +11.42% | -11.52% | +34.91% | +21.63% | +116.53% | -58.81% | -11.14% | +26.60% | +650.06% | -82.91% | +282.40% | -66.99% | n/a |